Literature DB >> 501499

Renal vein renin measurements in normotensive children.

K G Gerdts, V Shah, J M Savage, M J Dillon.   

Abstract

Renal venous PRA was measured in 49 normotensive children without renal disease undergoing routine cardiac catheterization. PRA levels did not differ significantly between both renal veins and were significantly higher in the renal veins than in the IVC. There was a constant mean ratio of 1.21 between the renal veins and the IVC at low, intermediate, and high absolute PRA levels. Three patients had a renal venous PRA ratio greater than 1.4 and the highest ratio observed was 1.55. This fidning supports 1.5 as an acceptable upper limit of normality for the interpretation of renal vein PRA ratios in the investigation of patients with suspected renal hypertension. In four patients, PRA in the renal veins was significantly lower than in the IVC. The possibility of renin removal by these kidneys is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 501499     DOI: 10.1016/s0022-3476(79)80282-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  Recent advances in evaluation and management of childhood hypertension.

Authors:  M J Dillon
Journal:  Eur J Pediatr       Date:  1979-11       Impact factor: 3.183

2.  Hypertension in paediatrics: can pre- and post-captopril technetium-99m dimercaptosuccinic acid renal scans exclude renovascular disease?

Authors:  I Minty; M F Lythgoe; I Gordon
Journal:  Eur J Nucl Med       Date:  1993-08

3.  Transient renovascular hypertension in childhood.

Authors:  J Passwell; T Rosenthal; H Boichis; Z Barzilai; P A Vardy; Z Rubinstein; E Cohen
Journal:  Eur J Pediatr       Date:  1984-02       Impact factor: 3.183

4.  Renin-angiotensin-aldosterone system.

Authors:  M J Dillon
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

Review 5.  Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation.

Authors:  Zivile Bekassy; Ingrid Lopatko Fagerström; Michael Bader; Diana Karpman
Journal:  Nat Rev Immunol       Date:  2021-11-10       Impact factor: 108.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.